In the case of IFN-α/β, the ability to drive HSPCs into the cell cycle similarly affects LSCs, and can be exploited to impair their self-renewal to aid in their elimination, leading to long-term remissions in MPNs and other myeloid malignancies. The gene discussed is IFNA1; the disease is myeloid neoplasm.